Google News
Butantan’s Single-Dose Dengue Vaccine Shows Durable Protection in Phase 3 Trial Contagion LiveButantan dengue vaccine estimated to be 81% effective against severe disease for at least 5 ...
Source: Google News
Butantan’s Single-Dose Dengue Vaccine Shows Durable Protection in Phase 3 Trial Contagion LiveButantan dengue vaccine estimated to be 81% effective against severe disease for at least 5 years CIDRAP